Carrie Bourdow is the founder of Trevena. Trevena has raised $174M in total funding. Backed by Alta Partners, Polaris Ventures, New Enterprise Associates.
Carrie Bourdow was appointed Senior Vice President and Chief Commercial Officer at Trevena in May 2015, a clinical stage pharmaceutical company focused on biased ligands targeting G protein coupled receptors. She was later promoted to Executive Vice President and Chief Operating Officer in February 2018. Before joining Trevena, Bourdow held positions at Cubist Pharmaceuticals, Inc. and Merck & Co., Inc., accumulating over 25 years of experience in pharmaceutical sales and marketing.
Full founder directory · Investor directory · Company funding database · Fundraising library